Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion

BACKGROUND: Alzheimer’s disease (AD) remains to date an incurable disease with a long asymptomatic phase. Early diagnosis in peripheral biofluids has emerged as key for identifying subjects at risk and developing therapeutics and preventative approaches. OBJECTIVE: We apply proteomics discovery to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldem, Ece, Barve, Aatmika, Sallin, Olivier, Foucras, Sandrine, Annoni, Jean-Marie, Schmid, Adrien W., Alberi Auber, Lavinia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925122/
https://www.ncbi.nlm.nih.gov/pubmed/35360272
http://dx.doi.org/10.3233/ADR-210056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925122/
https://www.ncbi.nlm.nih.gov/pubmed/35360272
http://dx.doi.org/10.3233/ADR-210056

Ejemplares similares